Deutsch English Français

Contact

EP4208188

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP4208188

EP4208188 - ANALOGS OF HUMAN FIBROBLAST GROWTH FACTORS [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 15.08.2025 Database last updated on 28.03.2026
Former	Request for examination was made Status updated on 09.06.2023
Former	The international publication has been made Status updated on 25.02.2022
Most recent event Tooltip	20.02.2026	New entry: Reply to examination report
Applicant(s)	For all designated states Energesis Pharmaceuticals Inc. 700 Main Street Cambridge, MA 02139 / US
	[2023/28]
Inventor(s)	01 / BOSS, Olivier Cambridge, MA 02139 / US
	02 / FREEMAN, Brian Cambridge, MA 02139 / US
	[2023/28]
Representative(s)	Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR
	[2023/28]
Application number, filing date	21859105.5	19.08.2021
	[2023/28]
	WO2021US46602
Priority number, date	US202063067675P	19.08.2020 Original published format: US 202063067675 P
	[2023/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2022040375
	Date:	24.02.2022
	Language:	EN
	[2022/08]
	Type:	A1 Application with search report
	No.:	EP4208188
	Date:	12.07.2023
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.02.2022 takes the place of the publication of the European patent application.
	[2023/28]
Search report(s)	International search report - published on:	US	24.02.2022
	(Supplementary) European search report - dispatched on:	EP	09.08.2024
Classification	IPC:	A61K38/18, C07K14/50, A61P3/04, A61P3/06, A61P3/08, A61P3/10, A61K38/00	[2024/37]
	CPC:	C07K14/50 (EP,US); A61K38/1825 (EP); A61P3/00 (US); A61P3/04 (EP); A61P3/06 (EP); A61P3/08 (EP); (+) A61P3/10 (EP); A61K38/00 (EP); C07K2319/30 (EP,US) (-)
	Former IPC [2023/28]	A61K38/18, C07K14/50
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/28]
Title	German:	ANALOGE MENSCHLICHER FIBROBLASTEN-WACHSTUMSFAKTOREN	[2023/28]
	English:	ANALOGS OF HUMAN FIBROBLAST GROWTH FACTORS	[2023/28]
	French:	ANALOGUES DE FACTEURS DE CROISSANCE DE FIBROBLASTES HUMAINS	[2023/28]
Entry into regional phase	10.03.2023	National basic fee paid
	10.03.2023	Search fee paid
	10.03.2023	Designation fee(s) paid
	10.03.2023	Examination fee paid
Examination procedure	10.03.2023	Examination requested [2023/28]
	25.02.2025	Amendment by applicant (claims and/or description)
	25.02.2025	Date on which the examining division has become responsible
	19.08.2025	Despatch of a communication from the examining division (Time limit: M06)
	19.02.2026	Reply to a communication from the examining division
Fees paid	Renewal fee
	28.08.2023	Renewal fee patent year 03
	27.08.2024	Renewal fee patent year 04
	27.08.2025	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[E] WO2022246230 (ENERGESIS PHARMACEUTICALS INC et al.) [E] 1-14 * sequences 2-7 * * paragraph [0059] *
	International search	[X] US2008181887 (DALL-ACQUA WILLIAM et al.) [X] 1 * entire document *
		[A] US2010092997 (NAKAMURA KAZUYASU et al.) [A] 1-20 * entire document *
		[A] US2014315817 (SCHMIDT MICHAEL MARCH et al.) [A] 1-20 * entire document *
		[A] US2014170142 (LUBMAN OLGA et al.) [A] 1-20 * entire document *
	by applicant	"Molecular Cloning: A Laboratory Manual", 2001
		"Current Protocols in Molecular Biology; the series Methods in Enzymology", 2007, ACADEMIC

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.